Cargando…
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
BACKGROUND AND OBJECTIVES: There has been considerable interest in statins because of their pleiotropic effects beyond their lipid-lowering properties. Many of these pleiotropic effects are predominantly ascribed to Rho small guanosine triphosphatases (Rho GTPases) proteins. We aimed to genetically...
Autores principales: | Almramhi, Mona M., Finan, Chris, Storm, Catherine S., Schmidt, Amand F., Kia, Demis A., Coneys, Rachel, Chopade, Sandesh, Hingorani, Aroon D., Wood, Nick W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624499/ https://www.ncbi.nlm.nih.gov/pubmed/37657941 http://dx.doi.org/10.1212/WNL.0000000000207777 |
Ejemplares similares
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021) -
Using Mendelian randomization to understand and develop treatments for neurodegenerative disease
por: Storm, Catherine S, et al.
Publicado: (2020) -
Lipid lowering and Alzheimer disease risk: A mendelian randomization study
por: Williams, Dylan M., et al.
Publicado: (2019) -
Genetic drug target validation using Mendelian randomisation
por: Schmidt, Amand F., et al.
Publicado: (2020) -
Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders
por: Schmidt, A Floriaan, et al.
Publicado: (2023)